Oncology Clinical Trials in Austin, TX

As of September 2026, 116 paid clinical trials are recruiting for Oncology in Austin, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

119 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Austin, TX.

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Drug: ASP546C

Sites in Austin, San Antonio +12 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07488676·Phase 1, Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for ER+, HER 2- Breast Cancer

Sites in Austin, San Antonio +9 more locations

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18 - 99

Code: NCT07540572·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for Esophageal Squamous Cell Carcinoma

Sites in Austin, San Antonio +13 more locations

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18+

Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

for Endometrial Cancer

Sites in Austin, San Antonio +10 more locations

Sponsor: Whitehawk Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07444814·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

for Breast Cancer

Sites in Austin, San Antonio +15 more locations

Sponsor: Terremoto Biosciences Inc.

Sex: All·Age: 18+

Code: NCT07109726·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for Colorectal Cancer

Sites in Austin, Houston +20 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07023289·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Austin, Webster +15 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06820463·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Austin, Houston +15 more locations

Sponsor: Janssen Research & Development, LLC

Sex: Male·Age: 18+

Code: NCT06800313·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for Metastatic Solid Tumor

Sites in Austin, San Antonio +16 more locations

Sponsor: Coherus Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06657144·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

for Advanced Solid Tumor

Sites in Austin, San Antonio +9 more locations

Sponsor: Aulos Bioscience, Inc.

Sex: All·Age: 18+

Code: NCT05267626·Phase 1, Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for Non-Small Cell Lung Cancer

Drug: Bevacizumab

Sites in Austin, San Antonio +18 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05005403·Phase 1·Recruiting·Listed Aug 2021

Apply to this trial

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for SST2-positive Neuroendocrine Neoplasms

Sites in Austin, Houston +21 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT07129252·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for Multiple Myeloma

Drug: Elranatamab

Sites in Austin +16 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06057402·Phase 4·Recruiting·Listed Sep 2023

Apply to this trial

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Austin, San Antonio +11 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06657222·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Austin, Houston +10 more locations

Sponsor: Nuvation Bio Inc.

Sex: All·Age: 18+

Code: NCT07154706·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

for Advanced Non-squamous Non-small-cell Lung Cancer

Sites in Austin, Baytown +13 more locations

Sponsor: Genelux Corporation

Sex: All·Age: 18+

Code: NCT06463665·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Sites in Austin, The Woodlands +19 more locations

Sponsor: Loxo Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06588478·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for Non-small Cell Lung Cancer (NSCLC)

Sites in Austin, San Antonio +19 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05379985·Phase 1, Phase 2·Recruiting·Listed May 2022

Apply to this trial

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

Sites in Austin +13 more locations

Sponsor: Zenith Epigenetics

Sex: Male·Age: 18+

Code: NCT04986423·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for Solid Tumor

Sites in Austin, Dallas +13 more locations

Sponsor: NiKang Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06586957·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

for Advanced Cancer

Sites in Austin, The Woodlands +13 more locations

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05557045·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Austin, San Antonio +11 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023

Apply to this trial

A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for AML

Sites in Austin, Houston +19 more locations

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

for Breast Cancer

Sites in Austin, San Antonio +11 more locations

Sponsor: Processa Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06568692·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for Brain Cancer

Sites in Austin +15 more locations

Sponsor: Adela, Inc

Sex: All·Age: 40+·Accepts healthy volunteers

Code: NCT05366881·Recruiting·Listed May 2022

Apply to this trial

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for Cancer

Sites in Austin, Irving +13 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT06014658·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for Endometrial Cancer

Sites in Austin, San Antonio +17 more locations

Sponsor: Kartos Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT05797831·Phase 2, Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

for Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Austin, San Antonio +16 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07549412·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in Austin, Houston +13 more locations

Sponsor: BioNTech SE

Sex: Male·Age: 18+

Code: NCT07365995·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for PIK3CA Mutations

Sites in Austin +10 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07383506·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

for Cancer

Drug: SYS6043

Sites in Austin, San Antonio +3 more locations

Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07424547·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for Head and Neck Squamous Cell Carcinoma HNSCC

Sites in Austin, San Antonio +7 more locations

Sponsor: Sutro Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07227168·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

for Breast Cancer

Sites in Austin, Houston +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07222267·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for Advanced Solid Tumor, Adult

Sites in Austin +5 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

Sites in Austin, Houston +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

for Renal Cell Carcinoma

Sites in Austin, San Antonio +6 more locations

Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All·Age: 18+

Code: NCT06966024·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Austin, Houston +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT06167317·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

Sample Collection for Ongoing Research and Product Evaluation Study

for Breast Cancer

1 location in Austin

Sponsor: Natera, Inc.

Sex: All·Age: 18+

Code: NCT07318051·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Austin +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Austin, San Antonio +5 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Conditions in Oncology (Austin, TX)

Solid tumor· 24 Non-small cell lung cancer (NSCLC)· 22 Breast cancer· 13 Endometrial cancer· 13 Cancer (any)· 12 Ovarian cancer· 11 Head and neck cancer· 8 Triple-negative breast cancer· 7 Pancreatic cancer· 7 Prostate cancer· 7 Multiple myeloma· 7 Colorectal cancer· 6 Cervical cancer· 6 Acute myeloid leukemia (AML)· 6 Bladder cancer· 5 Fallopian tube cancer· 5 Neuroblastoma· 5 Lung cancer· 4 Gastric cancer· 4 Metastatic prostate cancer· 4 Non-Hodgkin lymphoma· 4 HER2-negative breast cancer· 3 Small cell lung cancer· 3 Metastatic colorectal cancer· 3 Chronic lymphocytic leukemia (CLL)· 3 Leukemia (other)· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 HER2-positive breast cancer· 2 Rectal cancer· 2 Esophageal cancer· 2 Liver cancer· 2 Kidney cancer· 2 Uterine cancer· 2 Follicular lymphoma· 2 Small lymphocytic lymphoma· 2 Hematologic malignancy· 2 Melanoma· 2 Metastatic breast cancer· 1 Colon cancer· 1 Glioblastoma· 1 Brain cancer· 1 Acute lymphoblastic leukemia· 1 Myelodysplastic syndromes (MDS)· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Thyroid cancer· 1 Sarcoma· 1 Osteosarcoma· 1 Rhabdomyosarcoma· 1 Pediatric cancer· 1 Mesothelioma· 1 Neuroendocrine tumors· 1